- Corporate Officers - S
- Smith Sandford D
Insider Trading History of Smith Sandford D
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Sandford D since 2005.
This trader's CIK number is 1243004.
At the time of last reporting, Smith Sandford D was the Director of Cytokinetics Inc. (stock ticker symbol CYTK).
Also see all insider trading activities at Cytokinetics Inc.
Note that in the past
SMITH SANDFORD D also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Novelion Therapeutics Inc. (NVLN) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NVLN | 0 | $0 | 0 | $0 | 456 | $0 |
Yearly summary of insider trading at Aegerion Pharmaceuticals, Inc. (AEGR) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | AEGR | 0 | $0 | 0 | $0 | 4,445 | $0 |
| 2013 | AEGR | 0 | $0 | 12,502 | $1,160,895 | 12,502 | $193,930 |
Yearly summary of insider trading at Genzyme Corp (GENZ) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | GENZ | 0 | $0 | 0 | $0 | 14,500 | $0 |
| 2010 | GENZ | 0 | $0 | 45,812 | $2,745,500 | 56,791 | $1,405,959 |
| 2009 | GENZ | 0 | $0 | 1,641 | $92,785 | 5,000 | $0 |
| 2008 | GENZ | 0 | $0 | 25,000 | $1,992,499 | 25,000 | $1,228,953 |
| 2007 | GENZ | 0 | $0 | 50,000 | $3,614,250 | 50,000 | $2,282,750 |
| 2006 | GENZ | 0 | $0 | 23,645 | $1,602,133 | 26,720 | $1,011,184 |
| 2005 | GENZ | 0 | $0 | 1,118 | $80,177 | 0 | $0 |
Yearly summary of insider trading at Cytokinetics Inc (CYTK) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | CYTK | 0 | $0 | 11,369 | $613,584 | 11,369 | $276,232 |
| 2021 | CYTK | 0 | $0 | 84,026 | $3,241,404 | 84,026 | $1,206,372 |
| 2020 | CYTK | 0 | $0 | 71,064 | $1,773,490 | 71,064 | $416,113 |
Yearly summary of insider trading at Ariad Pharmaceuticals Inc (ARIA) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | ARIA | 0 | $0 | 0 | $0 | 45,000 | $124,199 |
Yearly summary of insider trading at Seelos Therapeutics, Inc. (APRI) by Smith Sandford D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | APRI | 26,500 | $41,641 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Smith Sandford D:
1. Novelion Therapeutics Inc. (NVLN)
2. Aegerion Pharmaceuticals, Inc. (AEGR)
3. Genzyme Corp (GENZ)
4. Cytokinetics Inc (CYTK)
5. Ariad Pharmaceuticals Inc (ARIA)
6. Seelos Therapeutics, Inc. (APRI)
Table 1. Insider trading of Novelion Therapeutics Inc. (NVLN) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-01-27 | NVLN | Option Ex | 456 | .00 | 0 |
Table 2. Insider trading of Aegerion Pharmaceuticals, Inc. (AEGR) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-07-27 | AEGR | Option Ex | 2,222 | .00 | 0 |
| 2016-01-27 | AEGR | Option Ex | 2,223 | .00 | 0 |
| 2013-10-29 | AEGR | Option Ex | 2,502 | 15.00 | 37,530 |
| 2013-10-29 | AEGR | Sale | 2,502 | 95.00 | 237,690 |
| 2013-08-09 | AEGR | Option Ex | 10,000 | 15.64 | 156,400 |
| 2013-08-09 | AEGR | Sale | 8,463 | 92.33 | 781,414 |
| 2013-08-12 | AEGR | Sale | 1,537 | 92.25 | 141,791 |
Table 3. Insider trading of Genzyme Corp (GENZ) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-04 | GENZ | Option Ex | 14,500 | .00 | 0 |
| 2010-07-23 | GENZ | Sale | 32,041 | 64.53 | 2,067,701 |
| 2010-07-23 | GENZ | Option Ex | 32,041 | 43.88 | 1,405,959 |
| 2010-05-25 | GENZ | Sale | 8,887 | 45.61 | 405,336 |
| 2010-05-22 | GENZ | Option Ex | 5,000 | .00 | 0 |
| 2010-05-24 | GENZ | Option Ex | 15,000 | .00 | 0 |
| 2010-05-21 | GENZ | Option Ex | 4,750 | .00 | 0 |
| 2010-05-24 | GENZ | Sale | 1,525 | 48.93 | 74,618 |
| 2010-03-19 | GENZ | Sale | 3,359 | 58.90 | 197,845 |
| 2009-05-26 | GENZ | Sale | 1,641 | 56.54 | 92,785 |
| 2009-05-22 | GENZ | Option Ex | 5,000 | .00 | 0 |
| 2008-01-16 | GENZ | Sale | 20,181 | 79.70 | 1,608,425 |
| 2008-01-16 | GENZ | Option Ex | 20,181 | 49.85 | 1,006,123 |
| 2008-01-11 | GENZ | Option Ex | 4,719 | 46.24 | 218,206 |
| 2008-01-11 | GENZ | Sale | 4,719 | 79.70 | 376,104 |
| 2008-01-09 | GENZ | Option Ex | 100 | 46.24 | 4,624 |
| 2008-01-09 | GENZ | Sale | 100 | 79.70 | 7,970 |
| 2007-10-15 | GENZ | Sale | 25,000 | 74.77 | 1,869,250 |
| 2007-10-15 | GENZ | Option Ex | 25,000 | 46.24 | 1,156,000 |
| 2007-10-10 | GENZ | Sale | 25,000 | 69.80 | 1,745,000 |
| 2007-10-10 | GENZ | Option Ex | 25,000 | 45.07 | 1,126,750 |
| 2006-08-31 | GENZ | Option Ex | 14,220 | 32.52 | 462,434 |
| 2006-08-31 | GENZ | Sale | 11,145 | 66.23 | 738,133 |
| 2006-03-01 | GENZ | Option Ex | 12,500 | 43.90 | 548,750 |
| 2006-03-01 | GENZ | Sale | 12,500 | 69.12 | 864,000 |
| 2005-07-29 | GENZ | Sale | 1,118 | 71.72 | 80,177 |
Table 4. Insider trading of Cytokinetics Inc (CYTK) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-02 | CYTK | Option Ex | 11,369 | 24.30 | 276,232 |
| 2022-09-02 | CYTK | Sale | 11,369 | 53.97 | 613,584 |
| 2021-12-27 | CYTK | Option Ex | 28,290 | 20.45 | 578,615 |
| 2021-12-27 | CYTK | Sale | 28,290 | 45.79 | 1,295,399 |
| 2021-11-19 | CYTK | Option Ex | 29,032 | 12.03 | 349,342 |
| 2021-11-19 | CYTK | Sale | 29,032 | 41.20 | 1,196,263 |
| 2021-07-19 | CYTK | Option Ex | 11,965 | 10.68 | 127,786 |
| 2021-07-19 | CYTK | Sale | 11,965 | 29.00 | 346,985 |
| 2021-04-27 | CYTK | Sale | 9,739 | 27.75 | 270,257 |
| 2021-04-27 | CYTK | Option Ex | 9,739 | 10.62 | 103,379 |
| 2021-04-23 | CYTK | Option Ex | 5,000 | 9.45 | 47,250 |
| 2021-04-23 | CYTK | Sale | 5,000 | 26.50 | 132,500 |
| 2020-10-05 | CYTK | Option Ex | 5,936 | 7.37 | 43,748 |
| 2020-10-05 | CYTK | Sale | 5,936 | 30.00 | 178,080 |
| 2020-07-15 | CYTK | Option Ex | 6,667 | 6.21 | 41,402 |
| 2020-07-15 | CYTK | Sale | 6,667 | 29.00 | 193,343 |
| 2020-07-10 | CYTK | Sale | 6,667 | 28.00 | 186,676 |
| 2020-07-10 | CYTK | Option Ex | 6,667 | 6.21 | 41,402 |
| 2020-07-08 | CYTK | Option Ex | 1,434 | 6.21 | 8,905 |
| 2020-07-07 | CYTK | Sale | 11,742 | 26.50 | 311,163 |
| 2020-07-08 | CYTK | Sale | 1,434 | 27.00 | 38,718 |
| 2020-07-07 | CYTK | Option Ex | 11,742 | 6.46 | 75,912 |
| 2020-06-22 | CYTK | Sale | 10,000 | 24.50 | 245,000 |
| 2020-06-22 | CYTK | Option Ex | 10,000 | 4.44 | 44,400 |
| 2020-06-17 | CYTK | Sale | 6,907 | 23.00 | 158,861 |
| 2020-06-17 | CYTK | Option Ex | 6,907 | 6.81 | 47,036 |
| 2020-06-15 | CYTK | Option Ex | 6,666 | 6.30 | 41,995 |
| 2020-06-15 | CYTK | Sale | 6,666 | 22.00 | 146,652 |
| 2020-06-12 | CYTK | Option Ex | 15,045 | 4.74 | 71,313 |
| 2020-06-12 | CYTK | Sale | 15,045 | 20.94 | 314,997 |
Table 5. Insider trading of Ariad Pharmaceuticals Inc (ARIA) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-06-20 | ARIA | Option Ex | 45,000 | 2.76 | 124,199 |
Table 6. Insider trading of Seelos Therapeutics, Inc. (APRI) by Smith Sandford D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-10-22 | APRI | Buy | 8,300 | 1.52 | 12,649 |
| 2014-10-23 | APRI | Buy | 18,200 | 1.59 | 28,992 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Sandford D
(Director of Cytokinetics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.